Companies House 2024-04-01 2025-03-31 2025-03-31 false true iso4217:GBP xbrli:pure 05610068 2023-04-01 2024-03-31 05610068 2025-03-31 05610068 2024-04-01 2025-03-31 05610068 2024-03-31 05610068 curr:PoundSterling 2024-04-01 2025-03-31 05610068 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05610068 uk-bus:FRS102 2024-04-01 2025-03-31 05610068 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05610068 uk-bus:AbridgedAccounts 2024-04-01 2025-03-31 05610068 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 05610068 uk-bus:Director40 2024-04-01 2025-03-31 05610068 uk-bus:Director1 2024-04-01 2025-03-31 05610068 uk-bus:Director2 2024-04-01 2025-03-31 05610068 uk-bus:Director3 2024-04-01 2025-03-31 05610068 uk-bus:Director4 2024-04-01 2025-03-31 05610068 uk-bus:Director5 2024-04-01 2025-03-31 05610068 uk-bus:Director6 2024-04-01 2025-03-31 05610068 uk-bus:Director7 2024-04-01 2025-03-31 05610068 uk-bus:Director8 2024-04-01 2025-03-31 05610068 uk-bus:Director9 2024-04-01 2025-03-31 05610068 uk-bus:Director10 2024-04-01 2025-03-31 05610068 uk-bus:Director11 2024-04-01 2025-03-31 05610068 uk-bus:Director12 2024-04-01 2025-03-31 05610068 uk-bus:Director13 2024-04-01 2025-03-31 05610068 uk-bus:Director14 2024-04-01 2025-03-31 05610068 uk-bus:Director15 2024-04-01 2025-03-31 05610068 uk-bus:Director16 2024-04-01 2025-03-31 05610068 uk-bus:Director17 2024-04-01 2025-03-31 05610068 uk-bus:Director18 2024-04-01 2025-03-31 05610068 uk-bus:Director19 2024-04-01 2025-03-31 05610068 uk-bus:Director20 2024-04-01 2025-03-31 05610068 uk-bus:CompanySecretary1 2024-04-01 2025-03-31 05610068 core:AfterOneYear 2025-03-31 05610068 core:AfterOneYear 2024-03-31 05610068 core:WithinOneYear 2025-03-31 05610068 core:WithinOneYear 2024-03-31 05610068 core:WithinOneYear 2024-04-01 2025-03-31 05610068 core:AfterOneYear 2025-03-31 05610068 core:AfterOneYear 2024-03-31 05610068 core:AfterOneYear 2024-04-01 2025-03-31 05610068 core:ShareCapital 2025-03-31 05610068 core:ShareCapital 2024-03-31 05610068 core:SharePremium 2025-03-31 05610068 core:SharePremium 2024-03-31 05610068 core:OtherReservesSubtotal 2025-03-31 05610068 core:OtherReservesSubtotal 2024-03-31 05610068 core:RevaluationReserve 2025-03-31 05610068 core:RevaluationReserve 2024-03-31 05610068 core:RetainedEarningsAccumulatedLosses 2025-03-31 05610068 core:RetainedEarningsAccumulatedLosses 2024-03-31 05610068 core:Associate1 2024-04-01 2025-03-31 05610068 core:Associate1 2024-03-31 05610068 core:Associate1 2025-03-31 05610068 core:Associate2 2024-04-01 2025-03-31 05610068 core:Associate2 2024-03-31 05610068 core:Associate2 2025-03-31 05610068 core:Associate3 2024-04-01 2025-03-31 05610068 core:Associate3 2024-03-31 05610068 core:Associate3 2025-03-31 05610068 core:Associate4 2024-04-01 2025-03-31 05610068 core:Associate4 2024-03-31 05610068 core:Associate4 2025-03-31 05610068 core:Associate5 2024-04-01 2025-03-31 05610068 core:Associate5 2024-03-31 05610068 core:Associate5 2025-03-31 05610068 core:Associate6 2024-04-01 2025-03-31 05610068 core:Associate6 2024-03-31 05610068 core:Associate6 2025-03-31 05610068 core:Associate7 2024-04-01 2025-03-31 05610068 core:Associate7 2024-03-31 05610068 core:Associate7 2025-03-31 05610068 core:Associate8 2024-04-01 2025-03-31 05610068 core:Associate8 2024-03-31 05610068 core:Associate8 2025-03-31 05610068 core:Associate9 2024-04-01 2025-03-31 05610068 core:Associate9 2024-03-31 05610068 core:Associate9 2025-03-31 05610068 core:Associate10 2024-04-01 2025-03-31 05610068 core:Associate10 2024-03-31 05610068 core:Associate10 2025-03-31 05610068 core:Associate11 2024-04-01 2025-03-31 05610068 core:Associate11 2024-03-31 05610068 core:Associate11 2025-03-31 05610068 core:Associate12 2024-04-01 2025-03-31 05610068 core:Associate12 2024-03-31 05610068 core:Associate12 2025-03-31 05610068 core:Associate13 2024-04-01 2025-03-31 05610068 core:Associate13 2024-03-31 05610068 core:Associate13 2025-03-31 05610068 core:Associate14 2024-04-01 2025-03-31 05610068 core:Associate14 2024-03-31 05610068 core:Associate14 2025-03-31 05610068 core:Associate15 2024-04-01 2025-03-31 05610068 core:Associate15 2024-03-31 05610068 core:Associate15 2025-03-31 05610068 core:Associate16 2024-04-01 2025-03-31 05610068 core:Associate16 2024-03-31 05610068 core:Associate16 2025-03-31 05610068 core:Associate17 2024-04-01 2025-03-31 05610068 core:Associate17 2024-03-31 05610068 core:Associate17 2025-03-31 05610068 core:Associate18 2024-04-01 2025-03-31 05610068 core:Associate18 2024-03-31 05610068 core:Associate18 2025-03-31 05610068 core:Associate19 2024-04-01 2025-03-31 05610068 core:Associate19 2024-03-31 05610068 core:Associate19 2025-03-31 05610068 core:Associate20 2024-04-01 2025-03-31 05610068 core:Associate20 2024-03-31 05610068 core:Associate20 2025-03-31 05610068 core:Associate1 2024-04-01 2025-03-31 05610068 core:Associate2 2024-04-01 2025-03-31 05610068 core:Associate3 2024-04-01 2025-03-31 05610068 core:Associate4 2024-04-01 2025-03-31 05610068 core:Associate5 2024-04-01 2025-03-31 05610068 core:Associate6 2024-04-01 2025-03-31 05610068 core:Associate7 2024-04-01 2025-03-31 05610068 core:Associate8 2024-04-01 2025-03-31 05610068 core:Associate9 2024-04-01 2025-03-31 05610068 core:Associate10 2024-04-01 2025-03-31 05610068 core:Associate11 2024-04-01 2025-03-31 05610068 core:Associate12 2024-04-01 2025-03-31 05610068 core:Associate13 2024-04-01 2025-03-31 05610068 core:Associate14 2024-04-01 2025-03-31 05610068 core:Associate15 2024-04-01 2025-03-31 05610068 core:Associate16 2024-04-01 2025-03-31 05610068 core:Associate17 2024-04-01 2025-03-31 05610068 core:Associate18 2024-04-01 2025-03-31 05610068 core:Associate19 2024-04-01 2025-03-31 05610068 core:Associate20 2024-04-01 2025-03-31 05610068 uk-bus:Director1 1 2024-04-01 2025-03-31 05610068 uk-bus:Director1 1 2024-03-31 05610068 uk-bus:Director1 1 2025-03-31 05610068 uk-bus:Director2 2 2024-04-01 2025-03-31 05610068 uk-bus:Director2 2 2024-03-31 05610068 uk-bus:Director2 2 2025-03-31 05610068 uk-bus:Director1 3 2024-04-01 2025-03-31 05610068 uk-bus:Director1 3 2024-03-31 05610068 uk-bus:Director1 3 2025-03-31 05610068 uk-bus:Director4 4 2024-04-01 2025-03-31 05610068 uk-bus:Director4 4 2024-03-31 05610068 uk-bus:Director4 4 2025-03-31 05610068 uk-bus:Director5 5 2024-04-01 2025-03-31 05610068 uk-bus:Director5 5 2024-03-31 05610068 uk-bus:Director5 5 2025-03-31 05610068 uk-bus:Director6 6 2024-04-01 2025-03-31 05610068 uk-bus:Director6 6 2024-03-31 05610068 uk-bus:Director6 6 2025-03-31 05610068 uk-bus:Director7 7 2024-04-01 2025-03-31 05610068 uk-bus:Director7 7 2024-03-31 05610068 uk-bus:Director7 7 2025-03-31 05610068 uk-bus:Director8 8 2024-04-01 2025-03-31 05610068 uk-bus:Director8 8 2024-03-31 05610068 uk-bus:Director8 8 2025-03-31 05610068 uk-bus:Director9 9 2024-04-01 2025-03-31 05610068 uk-bus:Director9 9 2024-03-31 05610068 uk-bus:Director9 9 2025-03-31 05610068 uk-bus:Director10 10 2024-04-01 2025-03-31 05610068 uk-bus:Director10 10 2024-03-31 05610068 uk-bus:Director10 10 2025-03-31 05610068 uk-bus:Director11 11 2024-04-01 2025-03-31 05610068 uk-bus:Director11 11 2024-03-31 05610068 uk-bus:Director11 11 2025-03-31 05610068 uk-bus:Director12 12 2024-04-01 2025-03-31 05610068 uk-bus:Director12 12 2024-03-31 05610068 uk-bus:Director12 12 2025-03-31 05610068 uk-bus:Director13 13 2024-04-01 2025-03-31 05610068 uk-bus:Director13 13 2024-03-31 05610068 uk-bus:Director13 13 2025-03-31 05610068 uk-bus:Director14 14 2024-04-01 2025-03-31 05610068 uk-bus:Director14 14 2024-03-31 05610068 uk-bus:Director14 14 2025-03-31 05610068 uk-bus:Director15 15 2024-04-01 2025-03-31 05610068 uk-bus:Director15 15 2024-03-31 05610068 uk-bus:Director15 15 2025-03-31 05610068 uk-bus:Director16 16 2024-04-01 2025-03-31 05610068 uk-bus:Director16 16 2024-03-31 05610068 uk-bus:Director16 16 2025-03-31 05610068 uk-bus:Director17 17 2024-04-01 2025-03-31 05610068 uk-bus:Director17 17 2024-03-31 05610068 uk-bus:Director17 17 2025-03-31 05610068 uk-bus:Director18 18 2024-04-01 2025-03-31 05610068 uk-bus:Director18 18 2024-03-31 05610068 uk-bus:Director18 18 2025-03-31 05610068 uk-bus:Director19 19 2024-04-01 2025-03-31 05610068 uk-bus:Director19 19 2024-03-31 05610068 uk-bus:Director19 19 2025-03-31 05610068 uk-bus:Director20 20 2024-04-01 2025-03-31 05610068 uk-bus:Director20 20 2024-03-31 05610068 uk-bus:Director20 20 2025-03-31 05610068 1 2024-04-01 2025-03-31 05610068 2 2024-04-01 2025-03-31 05610068 3 2024-04-01 2025-03-31

# PPIPL UK LIMITED

## Company Registration Number:
05610068 (England and Wales)

## Unaudited abridged accounts for the year ended 31 March 2025

## Period of accounts

## Start date: 01 April 2024

## End date: 31 March 2025

# PPIPL UK LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet |
Notes |

# PPIPL UK LIMITED

## Balance sheet

As at 31 March 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 138 | 184
Investments: | 4 | 1 | 1
Total fixed assets: |  | 139 | 185
Current assets
Debtors: |  | 558,411 | 573,080
Cash at bank and in hand: |  | 2,521 | 2,940
Total current assets: |  | 560,932 | 576,020
Creditors: amounts falling due within one year: |  | (309,752) | (317,038)
Net current assets (liabilities): |  | 251,180 | 258,982
Total assets less current liabilities: |  | 251,319 | 259,167
Creditors: amounts falling due after more than one year: |  | (205,000) | (205,000)
Total net assets (liabilities): |  | 46,319 | 54,167
Capital and reserves
Called up share capital: |  | 648,127 | 648,127
Profit and loss account: |  | (601,808) | (593,960)
Shareholders funds: |  | 46,319 | 54,167

The notes form part of these financial statements

# PPIPL UK LIMITED

## Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 14 November 2025
and signed on behalf of the board by:

Name: Vineet Sharma
Status: Director

The notes form part of these financial statements

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

## Turnover policy

REVENUE Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: SALE OF GOODS Revenue from the sale of goods is recognised when all of the following conditions are satisfied: - the Company has transferred the significant risks and rewards of ownership to the buyer; - the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; - the amount of revenue can be measured reliably; - it is probable that the Company will receive the consideration due under the transaction; and - the costs incurred or to be incurred in respect of the transaction can be measured reliably. RENDERING OF SERVICES Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: - the amount of revenue can be measured reliably; - it is probable that the Company will receive the consideration due under the contract; - the stage of completion of the contract at the end of the reporting period can be measured reliably; and - the costs incurred and the costs to complete the contract can be measured reliably. FINANCE COSTS Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument. PENSIONS The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds. INTEREST INCOME Interest income is recognised in profit or loss using the effective interest method.

## Tangible fixed assets and depreciation policy

TANGIBLE FIXED ASSETS Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis. Depreciation is provided on the following basis: - Fixtures and fittings at 25% Reducing balance method The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

## Valuation and information policy

VALUATION OF INVESTMENTS Investments in subsidiaries are measured at cost less accumulated impairment. Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment. Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

## Other accounting policies

FOREIGN CURRENCY TRANSLATION Functional and presentation currency The Company's functional and presentational currency is GBP. Transactions and balances Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Nonmonetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'. DEBTORS Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment. CASH AND CASH EQUIVALENTS Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. CREDITORS Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. FINANCIAL INSTRUMENTS The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan. Investments in non-derivative instruments that are equity to the issuer are measured: - at fair value with changes recognised in the Statement of comprehensive income if the shares are publicly traded or their fair value can otherwise be measured reliably; - at cost less impairment for all other investments. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date. Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or income as appropriate. The company does not currently apply hedge accounting for interest rate and foreign exchange derivatives.

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 2. Employees

| 2025 | 2024
--- | --- | ---
Average number of employees during the period | 3 | 4

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 3. Tangible Assets

| Total
--- | ---
Cost | £
At 01 April 2024 | 437
At 31 March 2025 | 437
Depreciation |
At 01 April 2024 | 253
Charge for year | 46
At 31 March 2025 | 299
Net book value |
At 31 March 2025 | 138
At 31 March 2024 | 184

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 4. Fixed investments

Cost £1.

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 5. Financial commitments

PENSION COMMITMENTS The Company operates a defined contributions pension scheme, The assets of the scheme are held separately from those of the Company in as independently administered fund. The pension cost charge represents contributions payable by the Company to the scheme and amounted to £292(£414 in 2024). No contributions were payable to the fund at the balance sheet date.

# PPIPL UK LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 6. Related party transactions

Name of the related party: | V Sharma and C B D Smith
Relationship: | Directors
Description of the Transaction: | Directors loan to the Company
£
Balance at 01 April 2024 |  | 83,778
Balance at 31 March 2025 |  | 119,077

Name of the related party: | V Sharma
Relationship: | Director
Description of the Transaction: | Loan to the Company.
£
Balance at 01 April 2024 |  | 205,000
Balance at 31 March 2025 |  | 205,000

Name of the related party: | Somerset Corporation Ltd
Relationship: | Associated company
Description of the Transaction: | Intercompany loan.
£
Balance at 01 April 2024 |  | 2,000
Balance at 31 March 2025 |  | 4,100